INDBInternet News Database 2.5 Updated 1 min ago · 316 sources Show or hide images Light or dark

Hims & Hers is launching five compounded peptide treatments not approved by the FDA

Save Like Comments Compare coverage
Image from Quartz

Summary

Hims & Hers customers may be prescribed Sermorelin, NAD+, Glutathione, Vitamin B12 and L-Carnitine after a provider visit

Description from Quartz.

Who is covering this

  1. Quartz Leans left Factuality: High US
    Hims & Hers is launching five compounded peptide treatments not approved by the FDA

    Hims & Hers customers may be prescribed Sermorelin, NAD+, Glutathione, Vitamin B12 and L-Carnitine after a provider visit

  2. CNBC Center Factuality: High US
    Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

    The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

Comments

Comments need JavaScript.